October 06, 2025

Dupilumab Shows High Treatment Persistence in AD

Biologics target type 2 inflammation in atopic dermatitis, improving skin barrier and symptoms.

Conexiant

October 03, 2025

CD19 CAR T-Cell Therapy May Be Effective in Treating Resistant Ulcerative Colitis

CAR T cells targeting CD19 in the treatment of multidrug-resistant ulcerative colitis appear to have induced rapid drug-free remission in refractory ulcerative colitis, a disease that is associated wi...

The ASCO Post

October 02, 2025

Digging for Antibiotics in Ancient Microbes

UPenn researchers use AI to discover thousands of potential new antibiotics from ancient microbes.

The Medicine Maker

October 02, 2025

Digital PCR Cuts Pathogen Detection Time

Digital PCR delivers faster blood pathogen detection than culture, identifying bacteria, fungi, and viruses.

Conexiant

October 02, 2025

Distal vs Shaft Tibia Fractures in Children

Open distal tibia fractures in pediatric patients are more severe than shaft fractures.

Conexiant

October 01, 2025

Remibrutinib Gains FDA Nod for Urticaria

First oral BTK inhibitor approved for antihistamine-resistant chronic spontaneous urticaria, targeting mast cell–driven immune dysregulation

Conexiant

October 01, 2025

Digital Lab OS: The Missing Link in Laboratory Automation

Laying the conceptual foundation for digital transformation – with a glimpse of how it is taking shape today

The Medicine Maker

October 01, 2025

Dry Eye Disease: The Vicious Cycle of Frustration and Search for Relief

Marjan Farid, MD, shares her insights on why patients discontinue treatments or cycle through different existing ones, what low compliance means for long-term patient outcomes, and what the physician and staff can do to address this.

Ophthalmic Professional

October 01, 2025

The True Extent of DED

Dry eye affects over half the population, yet few are diagnosed or treated

The Ophthalmologist